Locate family members with the last name PROSSER-LOOSE.

Erin Prosser-Loose is an academic who published a paper in 2018-07-07 entitled The protocol for the Cannabidiol in children with refractory epileptic encephalopathy (CARE-E) study: a phase 1 dosage escalation study. The paper was published in a journal entitled BMC Pediatrics.

ERIN PROSSER-LOOSE is an academic who published a paper in 2018 entitled The protocol for the Cannabidiol in children with refractory epileptic encephalopathy (CARE-E) study. ERIN PROSSER-LOOSE published this work as part of a team: Reithmeier, Darren. Here is a description of this work: Bac,,ground: Initial studies suggest pharmaceutical grade cannabidiol (CBD) can reduce the frequency of convulsive seizures and lead to improvements in quality of life in children affected by epileptic encephalopathies. With limited access to pharmaceutical CBD, Cannabis extracts in oil are becoming increasingly available. Physicians show reluctance to recommend Cannabis extracts given the lack of high quality safety data especially regarding the potential for harm caused by other cannabinoids, such as Î"9-tetrahydrocannabinol (Î"9-THC). The primary aims of the study presented in this protocol are (i) To determine whether CBD enriched Cannabis extract is safe and well-tolerated for pediatric patients with refractory epilepsy, (ii) To monitor the effects of CBD-enriched Cannabis extract on the frequency and duration of seizure types and on.